Viewing Study NCT00063895


Ignite Creation Date: 2025-12-24 @ 1:37 PM
Ignite Modification Date: 2026-01-07 @ 7:02 AM
Study NCT ID: NCT00063895
Status: COMPLETED
Last Update Posted: 2013-01-09
First Post: 2003-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module